SynthesisBMC infectious diseases2016

The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.

Fang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.